Skip to main content

Duke Settles Negligence Suit

Participants in controversial cancer trials have “resolved and settled all claims against” Duke University and oncologist Anil Potti, who previously admitted to fraud, lawyer says.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

WIKIMEDIA, CARINE06Nearly four years ago, patients who participated in clinical trials led by oncologist Anil Potti—formerly of Duke University—and the families of patients who had died sued the researcher and the school for “fraudulent and negligent behavior” after Potti admitted to fabricating statistical analyses of chemotherapy’s effects on breast cancer, among other acts of misconduct. That suit has now been settled, Retraction Watch reported last week (May 1).

Thomas Henson, counsel for the plaintiffs, told Retraction Watch: “Our clients and Duke University Health System have resolved and settled all claims against the current defendants arising out of the genomics-based clinical trials for cancer treatment. The specific terms of the settlement are confidential, by mutual agreement of the parties.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Illustrated floating metabolites and molecules

Metabolon Verus™ Kit: Metabolomics Profiling Kit

Metabolon
Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics